CPIG
ADVM

Chicago Partners Investment Group’s Adverum Biotechnologies ADVM Stock Holding History

Chicago Partners Investment Group’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,615
Closed -$112K – 585
2021
Q2 		$112K Buy
4,615
+2,240
+94% +$121K 0.01% 518
2021
Q1 		$237K Buy
2,375
+953
+67% +$114K 0.02% 451
2020
Q4 		$190K Buy
+1,422
New +$176K 0.02% 444

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chicago Partners Investment Group's ADVM Position: Q3 2021 in Review

Chicago Partners Investment Group sold out of Adverum Biotechnologies (ADVM) in Q3 2021, closing a stake of 4,615 shares — an estimated $112K sold.

Chicago Partners Investment Group first reported a position in ADVM in Q4 2020 and held it in 3 quarters. The position peaked at $237K in Q1 2021. 110 funds tracked by Wall St. Rank hold ADVM as of Q3 2021.

  • Chicago Partners Investment Group reported no remaining Adverum Biotechnologies position as of Q3 2021 after selling out during the quarter.
  • Chicago Partners Investment Group sold 4,615 Adverum Biotechnologies shares in Q3 2021, an estimated $112K.
  • Chicago Partners Investment Group first reported a position in Adverum Biotechnologies in Q4 2020 and held it in 3 quarters.
  • Chicago Partners Investment Group's Adverum Biotechnologies position peaked at $237K in Q1 2021.
  • 110 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2021.

Based on Chicago Partners Investment Group's 13F filing for Q3 2021, filed 12 Nov 2021.